Virtus ETF Advisers’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$343K Buy
+11,191
New +$251K 0.13% 205

Other funds holding CAI

Virtus ETF Advisers's CAI Position: Q3 2026 in Review

Virtus ETF Advisers opened a new position in Caris Life Sciences (CAI) in Q3 2026: 11,191 shares worth $343K. The stake represents 0.13% of the portfolio and ranks #205 among its holdings.

328 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Virtus ETF Advisers held 11,191 shares of Caris Life Sciences worth $343K as of Q3 2026.
  • Caris Life Sciences was a new Virtus ETF Advisers position in Q3 2026.
  • Caris Life Sciences made up 0.13% of Virtus ETF Advisers's portfolio in Q3 2026, its #205 holding.
  • 328 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.